Given that microglia-derived neuroinflammation is involved in ALS pathology (Geloso et al., 2017; Liu and Wang, 2017), TREM2 is thought to play a role in the regulation of microglial activity in ALS. Here, TREM2 is linked to amyotrophic lateral sclerosis.